Aristotle University Of Thessaloniki (AUTH)
Ανάπτυξη μικροβελόνων για διαδερμική χορήγηση φαρμάκων που δρουν στο νευρικό σύστημα με την τεχνολογία της τρισδιάστατης εκτύπωσης
Abstract
dc:descriptionThe ever-increasing need of patients for personalized treatment has led to continuous research into new and innovative pharmaceutical formulations that can be administered by alternative routes of delivery. For this reason, alternative routes such as buccal, nasal and transdermal routes have been proposed. The transdermal route is the administration of drugs through the skin. This route of administration has several advantages as the skin is one of the largest organs in the body, it has a very large surface area and the active pharmaceutical ingredients (APIs) avoid the first-pass effect from the liver. There are already commercial formulations intended for the skin, but the major disadvantage of the skin is its outermost layer - the stratum corneum - which is the main barrier to the absorption of active substances. Many ways have been proposed to increase the absorption through the skin. One of them is the use of microneedles. This is an innovative, non-invasive delivery system consisting of very small needles that have the ability to penetrate the stratum corneum and release the drug into the epidermis. In this way, the stratum corneum is bypassed and the absorption of the drugs is greatly increased. The need for personalized transdermal treatment with microneedles led to their three-dimensional (3D printed) development. In the present study, microneedles were developed for transdermal delivery of drugs acting on the nervous system and prescribed in cases of patients suffering from dementia. Dementia is the most common symptom of Alzheimer's disease and leads to a decrease in the cognitive abilities of the individual. 3D printing has been combined with other cutting-edge technologies to produce innovative microneedle arrays. In this thesis, 4 types of needles were developed. In the first study, coated microneedles with PLGA particles containing two active substances, rivastigmine and N-acetylcysteine, were developed. Electrospraying was applied to produce the particles, and the arrays were printed using Digital Light Processing (DLP) technology. In the second study, coated microneedles were developed by combining two 3D printing techniques, DLP and Semi solid extrusion. The two techniques were perfectly combined and produced microneedles in a safe, fast and reliable way. Donepezil, the active substance incorporated in the study was formulated with a polymer, demonstrating a controlled release behavior. In the third study, 3D printing was applied as an indirect method. It was used to print microneedles which then served as templates for the fabrication of negatives, which acted as molds for casting. A novel technique, Vacuum Compression Molding, was also used for casting, in which microneedles were made from rivastigmine and a polymer. The process was fast and did not require the preparation of aqueous solutions, which is extremely useful for insoluble substances. Finally, a liquid resin was prepared in the laboratory from macromonomers and hydrogel microneedles were printed, which release the drug through water adsorption. Therefore, this thesis, combined 3D printing with different techniques and was able to develop microneedles with different characteristics.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Monou, Paraskevi-Kyriaki
- Μόνου, Παρασκευή-Κυριακή
Subjects
dc:subject × 20- Τρισδιάστατη εκτύπωση
- Μικροβελόνες
- Διαδερμική χορήγηση
- Νευρικό σύστημα
- 3d printing
- Microneedles
- Transdermal delivery
- Nervous system
- Άλλες Επιστήμες Μηχανικού και Τεχνολογίες
- Επιστήμες Μηχανικού και Τεχνολογία
- Μηχανική και Τεχνολογίες, άλλοι τομείς
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, άλλοι τομείς
- Other Engineering and Technologies
- Engineering and Technology
- Engineering and Technologies, miscellaneous
- Health Sciences
- Medical and Health Sciences
- Health sciences, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57826